Keywords: GlaxoSmithKline, Innovation Fund, Canada

GlaxoSmithKline launches $50 million Life Sciences Innovation Fund in Canada

Article | 13 November 2011

Print This

UK pharma giant GlaxoSmithKline (LSE: GSK) has launched the GSK Canada Life Sciences Innovation Fund, a new national $50 million fund ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in